Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Erholung nach Ermüdung bei jungen Sportlern: Vergleich zwischen TECAR-Therapie und Fahrradergometer

Akute und kurzfristige Auswirkungen der TECAR-Therapie und des Fahrradergometers auf die Erholung nach Ermüdung bei jungen Sportlern: eine randomisierte kontrollierte Studie

The goal of this clinical trial is to compare two recovery methods after fatigue in young athletes. It aims to find out if tecar therapy (TECAR) or cycle ergometer exercise can improve recovery after intense physical activity and help athletes return to their normal performance more quickly.

The main questions it aims to answer are:

Does TECAR or cycle ergometer improve physical performance after fatigue?

Do these methods reduce muscle pain and soreness after fatigue?

Researchers will compare TECAR with active recovery using a cycle ergometer to see which method is more effective.

Participants will:

Perform a series of jumps to induce fatigue

Be randomly assigned to one of the recovery methods

Complete physical tests before and after fatigue

Undergo simple measurements of muscle condition and pain

Report their level of effort and muscle soreness

Studienübersicht

Detaillierte Beschreibung

This study is a randomized controlled trial designed to evaluate and compare the effectiveness of two recovery strategies following exercise-induced fatigue in young athletes: tecar therapy (TECAR) and active recovery (usual care) using a cycle ergometer.

Exercise-induced fatigue can reduce physical performance and increase muscle soreness, which may negatively affect athletic performance and increase injury risk. This study aims to compare the effects of two commonly used recovery strategies on physical performance, muscle mechanical properties, and perceived recovery.

Participants will be physically active young athletes over 18 years of age, familiar with plyometric or jump-based activities. They will be recruited through convenience sampling. Individuals with recent musculoskeletal injuries or those who have performed intense physical exercise within 24 hours prior to testing will be excluded.

All procedures will be conducted in a controlled environment by trained personnel following a standardized protocol. After providing informed consent, participants will undergo baseline assessments, including physical performance tests, measurements of muscle mechanical properties, and subjective perception of effort and muscle soreness.

A standardized warm-up will be performed prior to testing, consisting of low-intensity aerobic activity for approximately five minutes, aiming to reach a moderate level of perceived exertion.

Participants will then complete a fatigue protocol consisting of repeated drop jumps from a fixed height of approximately 0.6 meters. The protocol will be organized into multiple sets with controlled rest intervals between repetitions and sets in order to induce acute neuromuscular fatigue in a standardized manner.

Immediately after the fatigue protocol, the same assessments will be repeated to evaluate the acute effects of fatigue.

Participants will then be randomly assigned to one of the two recovery interventions:

TECAR: application of capacitive and resistive electric transfer using radiofrequency energy for 20 minutes

Active recovery (usual care): continuous cycling on a cycle ergometer at low-to-moderate intensity for 20 minutes, reflecting standard recovery practices commonly used in athletic settings

Following the assigned recovery intervention, all assessments will be repeated to evaluate recovery effects.

In addition, subjective measures of muscle soreness and perceived effort will be collected at 12 and 24 hours after the intervention to assess short-term recovery.

Outcome measures will include objective indicators of physical performance and muscle mechanical properties, assessed using a handheld myotonometer, as well as pressure pain threshold (a measure of sensitivity to pressure), and subjective measures related to perceived effort and muscle soreness.

Statistical analysis will include descriptive statistics and inferential analysis to compare differences between groups and over time. A two-way analysis of variance (group × time) will be used to evaluate the effects of the recovery intervention and measurement time points, including potential interaction effects. Statistical significance will be set at p < 0.05.

This study aims to provide evidence on the comparative effectiveness of TECAR and active recovery strategies, contributing to the optimization of recovery protocols in athletic populations.

Studientyp

Interventionell

Einschreibung (Geschätzt)

48

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

  • Name: Sandra Alcaraz Clariana, PhD PT
  • Telefonnummer: +34625434043
  • E-Mail: m72alcls@uco.es

Studieren Sie die Kontaktsicherung

  • Name: Lourdes García Luque, PhD PT
  • Telefonnummer: +34627366324
  • E-Mail: z12galul@uco.es

Studienorte

    • Córdoba
      • Córdoba, Córdoba, Spanien, 14011
        • Rekrutierung
        • Physiobalance
        • Kontakt:
          • Sandra Alcaraz Clariana, PhD PT
          • Telefonnummer: +34625434043
          • E-Mail: m72alcls@uco.es
        • Kontakt:
          • Lourdes García Luque, PhD PT
          • Telefonnummer: +34627366324
          • E-Mail: z12galul@uco.es
        • Hauptermittler:
          • Sandra Alcaraz Clariana, PhD PT
        • Unterermittler:
          • Lourdes García Luque, PhD PT

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Adults aged 18 years or older
  • Engaging in regular physical activity
  • Experience with sports involving jumping or plyometric exercises

Exclusion Criteria:

  • Performed intense physical exercise within 24 hours before the study
  • Planned to perform intense physical exercise within 24 hours after the study
  • Presence of muscle soreness at the beginning of the study
  • Musculoskeletal injury in the previous 6 months

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: TECAR

Participants assigned to this group will receive tecar therapy (TECAR) for 20 minutes. TECAR will be applied using the capacitive mode only, combining manual mobile application and fixed automatic application. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants.

TECAR is applied using capacitive radiofrequency energy for 20 minutes following a standardized fatigue protocol. The intervention is delivered using capacitive mode only, combining manual mobile application and fixed automatic application over the quadriceps region to promote recovery after exercise-induced fatigue.

Andere Namen:
  • Kapazitive und resistive elektrische Transfertherapie. Radiofrequenztherapie
Aktiver Komparator: Active recovery (usual care)

Participants assigned to this group will perform active recovery (usual care) consisting of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants. This intervention reflects standard recovery practices commonly used in athletic settings.

Active recovery consists of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. This intervention is performed after a standardized fatigue protocol and reflects common recovery practices in athletic settings.

Andere Namen:
  • Radfahren mit geringer Intensität

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Countermovement jump height
Zeitfenster: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Vertical jump performance will be assessed using a countermovement jump test. Jump height will be measured using a validated mobile application after three attempts, and the mean value will be recorded.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Muscle mechanical properties
Zeitfenster: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Muscle mechanical properties will be assessed using a handheld myotonometer. Parameters will include muscle tone and stiffness measured at standardized anatomical locations of the rectus femoris, vastus lateralis, medial gastrocnemius, and lateral gastrocnemius.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
Pressure pain threshold
Zeitfenster: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).

Pressure pain threshold will be assessed using a handheld algometer. Measurements will be performed at standardized anatomical locations of the rectus femoris, vastus lateralis, and medial gastrocnemius, and the mean of repeated measurements will be recorded.

Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
Rating of perceived exertion
Zeitfenster: Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.

Perceived exertion will be assessed using a 0-10 rating scale, where higher values indicate greater perceived effort.

Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.
Delayed-onset muscle soreness.
Zeitfenster: Baseline (after warm-up), 12 hours, and 24 hours.

Delayed-onset muscle soreness (DOMS) will be assessed using a 0-10 numeric rating scale, where 0 indicates no muscle soreness and 10 indicates the worst possible muscle soreness.

Baseline (after warm-up), 12 hours, and 24 hours.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Sandra Alcaraz Clariana, PhD PT, Maimonides Biomedical Research Institute of Cordoba (IMIBIC). Department of Nursing, Pharmacology and Physical Therapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain;

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

27. April 2026

Primärer Abschluss (Geschätzt)

1. Dezember 2026

Studienabschluss (Geschätzt)

1. Februar 2027

Studienanmeldedaten

Zuerst eingereicht

26. März 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. April 2026

Zuerst gepostet (Tatsächlich)

23. April 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

5. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

3. November 2026

Zuletzt verifiziert

1. März 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren